IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
33.19
+0.16 (0.48%)
At close: Mar 6, 2026, 4:00 PM EST
33.85
+0.66 (1.99%)
After-hours: Mar 6, 2026, 7:36 PM EST
IDEAYA Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 218.71 | 7 | 23.39 | 50.93 | 27.94 | |
| Revenue Growth (YoY) | 3024.43% | -70.07% | -54.09% | 82.28% | 43.01% | |
| Cost of Revenue | 314.7 | 294.67 | 129.51 | 89.54 | 58.16 | |
| Gross Profit | -95.99 | -287.67 | -106.12 | -38.61 | -30.22 | |
| Selling, General & Admin | 63.32 | 39.3 | 28.31 | 23.9 | 20.05 | |
| Operating Expenses | 63.32 | 39.3 | 28.31 | 23.9 | 20.05 | |
| Operating Income | -159.31 | -326.98 | -134.43 | -62.5 | -50.27 | |
| Interest & Investment Income | 35.64 | 29.27 | 9.92 | 3.15 | 2.34 | |
| EBT Excluding Unusual Items | -123.67 | -297.71 | -124.51 | -59.35 | -47.93 | |
| Gain (Loss) on Sale of Investments | 9.98 | 23.23 | 11.55 | 0.7 | -1.83 | |
| Pretax Income | -113.7 | -274.48 | -112.96 | -58.66 | -49.76 | |
| Net Income | -113.7 | -274.48 | -112.96 | -58.66 | -49.76 | |
| Net Income to Common | -113.7 | -274.48 | -112.96 | -58.66 | -49.76 | |
| Shares Outstanding (Basic) | 88 | 82 | 58 | 41 | 35 | |
| Shares Outstanding (Diluted) | 88 | 82 | 58 | 41 | 35 | |
| Shares Change (YoY) | 8.33% | 42.00% | 38.79% | 17.57% | 42.60% | |
| EPS (Basic) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | |
| EPS (Diluted) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | |
| Free Cash Flow | -73.47 | -251.44 | -117.59 | -90.62 | -58.42 | |
| Free Cash Flow Per Share | -0.83 | -3.08 | -2.04 | -2.19 | -1.66 | |
| Gross Margin | -43.89% | - | - | -75.80% | -108.15% | |
| Operating Margin | -72.84% | -4671.07% | -574.85% | -122.72% | -179.91% | |
| Profit Margin | -51.99% | -3921.10% | -483.05% | -115.17% | -178.10% | |
| Free Cash Flow Margin | -33.59% | -3592.01% | -502.85% | -177.92% | -209.09% | |
| EBITDA | -156.61 | -324.59 | -131.95 | -60.4 | -48.54 | |
| EBITDA Margin | -71.61% | - | - | -118.59% | -173.73% | |
| D&A For EBITDA | 2.7 | 2.39 | 2.48 | 2.1 | 1.73 | |
| EBIT | -159.31 | -326.98 | -134.43 | -62.5 | -50.27 | |
| EBIT Margin | -72.84% | - | - | -122.72% | -179.91% | |
| Revenue as Reported | 218.71 | 7 | 23.39 | 50.93 | 27.94 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.